How Much Longer Will We Put Up With $100,000 Cancer Drugs?

Cell. 2017 Feb 9;168(4):579-583. doi: 10.1016/j.cell.2017.01.034.


The spiraling cost of new drugs mandates a fundamentally different approach to keep lifesaving therapies affordable for cancer patients. We call here for the formation of new relationships between academic drug discovery centers and commercial partners, which can accelerate the development of truly transformative drugs at sustainable prices.

MeSH terms

  • Antineoplastic Agents / economics*
  • Antineoplastic Agents / therapeutic use
  • Drug Approval
  • Drug Costs* / legislation & jurisprudence
  • Drug Discovery
  • Health Care Costs
  • Humans
  • Neoplasms / drug therapy*
  • United States


  • Antineoplastic Agents